Motivation and emotion/Book/2021/Synthetic cannabinoids and emotion

Synthetic cannabinoids and emotion:
What are the emotional effects of synthetic cannabinoids?

Multimedia presentation (3 min)

Overview

Synthetic cannabinoids are psychoactive chemicals that interact with cannabinoid receptors in the brain and central nervous system (CNS), altering neurotransmitter activity (Alexandre et al., 2020). This chapter aims to understand the role of synthetic cannabinoids on neuronal functioning to explain the emotional and physical impact of consumption. Current research has determined that synthetic cannabinoids produce more adverse effects than natural cannabinoids due to the higher binding affinity and full-agonist activity toward the Cannabinoid-1 (CB1) and Cannabinoid-2 receptors (CB2) (Sutcliffe & Ralphs, 2018; Wells et al., 2011). The impact of consumption of synthetic cannabis will be discussed, including acute versus chronic intoxication, and outlining the psychical, behavioural, cognitive, and psychosocial symptoms.

Focus questions: What are synthetic cannabinoids? What is the history of synthetic cannabinoids? How are synthetic cannabinoids produced? How do synthetic cannabinoids impact users in the short term? How do synthetic cannabinoids impact users in the long term? How do synthetic cannabinoids impact emotions and emotional processing? What is the impact of quitting and withdrawal on emotions?

History and Prevalence of Synthetic Cannabinoids

Synthetic Cannabis

• The first synthetic cannabinoid was developed by the organic chemist John Huffman of Clemson University in 2008. The active ingredient in synthetic cannabis is JWH-o18, a naphthoylindole, belonging to the aminoalkylindole family, which are cannabinergic compounds that pose as cannabinoid receptor agonists. Despite JWH-o18 having a different chemical structure to Tetrahydrocannabinol (THC), the effects are similar (Byard & Payne-James, 2015).
• Production of synthetic cannabinoids begins on a large scale in China. A bulk powder is produced via simple chemical reactions using legal substances (Sutcliffe & Ralphs, 2018). The bulk powder is then shipped to Europe and mixed or sprayed onto dried plant material that does not contain tobacco or cannabis. The material is dried and packaged as an air freshener, incense, or a smoking mix, and is distributed to other countries including America and England to sell (Sutcliffe & Ralphs, 2018).
• Synthetic cannabis is legally sold in many countries and is available to purchase online or in head shops (Cottencin et al., 2014).
• Synthetic cannabinoids are known as K2 or Spice but have many other names (Sutcliffe & Ralphs, 2018). Similarly, synthetic cannabis has many different chemical formulations - the contents are unknown (Wells et al., 2011), this causes unpredictable reactions after intoxication due to the varying potential toxicity (Millis et al., 2018).
• Synthetic cannabinoid products first appeared on the internet for sale in 2006. Popularity began in 2008 when a German reporter announced that Spice had a similar high to natural marijuana but did not appear in drug tests (Sutcliffe & Ralphs, 2018). The unpredictability of synthetic cannabinoids combined with the inability to be detected in urine drug tests pose a large public health concern (Millis et al., 2018).

Synthetic Cannabinoids and Short Term Impacts

Acute intoxication of synthetic cannabinoids can cause users to experience both positive and negative effects due to the varying binding affinity to the CB1 and CB2 receptors (Wells et al., 2011).

Case Study Part 1: Short Term Effects, Acute Intoxication and Hangover Lana first tried synthetic marijuana at the age of 17. She brought it under the name “Spice”, her dealer told her it was natural weed. Lana met with a friend and smoked a joint, having a good time, she felt happy and relaxed. The next day Lana experienced a low mood accompanied by headaches and feeling disconnected from reality (Soussan et al., 2014).

Description of Synthetic Cannabinoids:

Ball-and-stick model of JWH-018—a synthetic cannabinoid receptor agonist.

• Synthetic cannabinoids such as JWH-018 mimic the effect of THC (the main psychoactive component of cannabis) (Sutcliffe & Ralphs, 2018), Lana's acute intoxication caused her to experience positive and happy feelings. This euphoric effect caused by synthetic cannabis is common as the chemical structure of JWH-018 produces similar effects to natural marijuana (THC) (Wells et al., 2011). Despite Lana's positive experience, acute intoxication of synthetic cannabis can also cause users to experience fear, paranoia, nausea and dizziness, respiratory difficulties, and tachycardia (Akram et al., 2019).

Neurology

• JWH-018 is the most common synthetic cannabinoid compound found in Spice and K2. Synthetic cannabis is abused due to the full-agonist activity to the CB1 and CB2 receptors (Wells et al., 2011). Synthetic cannabinoids have a higher affinity for the CB1 and CB2 receptors than natural cannabinoids. THC is a partial agonist, whilst synthetic cannabinoids are full agonists (Zaleta et al., 2016), producing an effect four to five times stronger than natural marijuana (Wells et al., 2011).
• As synthetic cannabinoids vary in ingredients, they vary in affinity toward either the CB1 or CB2 receptor, producing unpredictable outcomes. A higher affinity toward the CB1 receptor produces more psychotropic effects, including alterations in mood, perceptions, and cognition due to the presence of the receptor in neuronal cells (Alexandre et al., 2020). Whilst having a higher affinity toward the CB1 receptor causes pain relief but reduced psychotropic effects (Alexandre et al., 2020).

CB1 Receptor

• The CB1 receptor produces euphoric feelings and psychoactive effects, including alterations in mood, perceptions and cognition (Wells et al., 2011; Alexandre et al., 2020). The receptors exist in neuronal cells within the brain, densely packed in the prefrontal cortex and the hippocampus, within the central nervous system, connective tissue, glands, organs, and gonads (Fantegrossi et al., 2018; Alexandre et al., 2020; Samaan et al., 2016). The location of these receptors explains why users experience nausea relief and a sense of euphoria (Samaan et al., 2016). The binding of the CB1 receptors inhibits the release of hormones including acetylcholine, noradrenaline, GABA and glutamate, altering brain functions including memory, cognition, motor cognition, and autonomic functioning (Alexandre et al., 2020).

CB2 Receptor

• The CB2 receptor is responsible for mood regulation, behavior regulation, and pain control, as the receptors are located in the immune system, nervous system, and gastrointestinal system (Fantegrossi et al., 2018; Wells et al., 2011). The CB2 receptor regulates the immune system and central nervous system as they are densely located in immune cells (Alexandre et al., 2020). The synthetic cannabinoids interact with the CB2 receptor, causing 2-Arachidonoylglycerol, an agonist to activate the CB2 receptors located in the brainstem to produce effects in the nervous system (Samaan et al., 2016). The cannabinoid interaction with the nervous system produces the pain relief that users experience after intoxication. The increased activity in the central nervous system can also cause agitation, explaining why users experience confusion or delusions (Samaan et al., 2016).

Hangover

• Lana’s symptoms of exhaustion and feeling sluggish are characterized by the ‘hangover’ period of using synthetic cannabis. This period causes users to feel dull, tired, monotonous, and dehydrated. (Akram et al., 2019). Users often develop a dependence to smoking synthetic cannabis to avoid this feeling.
• Users experience a zombie-like, emotionally numb state characterized by feelings of apathy and disconnect from reality. The constant feeling of depersonalization causes life to feel mundane, resulting in users losing interest in the things they normally would enjoy (Soussan et al., 2014).
• Research is limited in determining the cause of the hangover period but findings are consistent in multiple clinical case studies.

“It’s like losing the magic of life, the thing that makes me feel animated, soulful and having a personality.”

"The next day I feel lobotomized, and nothing is fun or boring.”

Comments from individuals who experienced the hangover period (Soussan et al., 2014)

Case Study Part 1: Quiz What receptor is responsible for Lana feeling happy? 1. The CB1 receptor 2. The CB2 receptor

Answer
1. Correct 2. Incorrect The CB1 receptor produces the happy feelings and psychoactive effects from the synthetic marijuana (Wells et al., 2011).

Memory Problems and Synthetic Cannabinoids

Long-term use of synthetic cannabinoids results in short-term and long-term disruptions in memory retention (Cohen et al., 2017).

Case Study Part 2: Memory Problems After smoking for four months, Lana has trouble remembering things, this interferes with her daily life as she cannot remember important events or recall the things she would do. Lana often feels confused and is not able to distinguish what is real and what is not, she is delusional and disorganized (Soussan et al., 2014)

Image identifies the hippocampal region in the brain. The hippocampus is responsible for memory formation.

• Chronic use of synthetic cannabinoids causes volume reductions and disruptions in the hippocampus, disrupting short-term and long-term memory retention (Wells, 2011; Cohen et al., 2017). Synthetic cannabinoids are agonists to the CB1 receptors located in the hippocampus, causing impairments in synaptic plasticity, and therefore, memory processes (Cohen et al., 2017). This explains Lana's inability to recall her memories.
• The hippocampus is responsible for encoding and acquiring new information. The new information is manipulated by the working memory system within the prefrontal cortex. Synthetic cannabinoids have deleterious effects, directly reducing hippocampal encoding ability, therefore, reducing input relay to the prefrontal cortex. This causes disruptions within the working memory system (Cohen et al., 2017).
• As the working memory system is responsible for complex cognitive tasks such as learning, comprehension, and stores and processes information, this can explain why Lana is having problems recalling her short-term memories and is delusional as her cognitive ability is negatively impacted.
• Synthetic cannabinoid abuse also affects the insula, anterior cingulate cortex, precuneus, inferior frontal gyrus, frontal orbital gyrus, and middle frontal gyrus. The functional and structural changes in these brain regions are responsible for the emotional disturbances in users, inducing feelings of confusion, loss, and feeling fragmented (Soussan et al., 2014).

“I tried watching Family Guy during intoxication, but the whole time I forgot what the episode was about.” (Soussan et al., 2014).

Users experience difficulties concentrating after consumption of synthetic cannabis, which can induce feelings of frustration (Soussan et al., 2014).

Case Study Part 2 Quiz: Memory Loss Why is Lana experiencing memory loss? 1. The synthetic cannabinoids interact with the amygdala causing disruptions in memory retention 2. The synthetic cannabinoids interact with the hippocampus causing disruptions in memory retention

Answer

1. Incorrect 2. Correct The hippocampus is responsible for storing and processing new information, therefore, the interaction of synthetic cannabis disrupts normal functioning, resulting in memory problems (Cohen et al., 2017).|} Synthetic Cannabinoids and Depression Chronic use of synthetic cannabinoids increases the risk of developing depression (Cohen et al., 2017). Case Study Part 3: Depression and Depersonalization Lana has been smoking for six months. She has experienced several depressive episodes since she began abusing synthetic cannabis but is enduring her worst episode yet. She feels emotionally numb, apathetic, and disconnected from reality (Cohen et al., 2017). She feels depersonalized, and her life feels mundane. She no longer has an interest in anything that she used to enjoy. She feels fatigued daily and also experiences headaches and nausea (Cohen et al., 2017). Emotionally numb ‘The drug-totally distorted my personality, it turned me inside out… it made me blunt, and switched off my brain’ (Akram et al., 2019) Mood changes ‘When I smoked I was wallowing in self-pity, I felt sorry for myself, I was alone, I didn’t care about anybody else, I hated everyone (Akram et al., 2019) Consumption and abuse of synthetic cannabinoids cause CB1 receptor agonists to induce a decrease in prefrontal serotonin levels. The decrease in serotonin alters cognitive functioning and specifically learning abilities (Cohen et al., 2017). The decrease in serotonin is responsible for Lana's depressive mood and feelings of apathy. The study by Akram et al. (2019) found significantly higher correlations of depression in synthetic cannabinoid users compared with natural cannabinoid users. Synthetic marijuana products have been found to contain large amounts of vitamin E, causing vitamin K to antagonize. Large amounts of vitamin K cause feelings of fatigue, headache, nausea, diarrhoea, and muscle weakness (Wells, 2011). The excess in vitamin E is responsible for producing Lana's low mood, fatigue, headaches, and nausea. Synthetic Cannabinoids Cause Cardiac Problems and Psychosis Chronic and long-term synthetic cannabinoid abuse is correlated with cardiac problems including tachycardia, and psychotic problems leading to the development of psychosis (Fantegrossi et al., 2018; Soussan et al., 2014). Case Study Part 4: Cardiac Problems and Psychosis Lana is admitted to the hospital after experiencing a rapid heart rate after smoking . Her roommate called an ambulance after finding her with chest pains and in a disoriented state screaming, ‘where am I?'. Her heart rate was abnormally high which caused her to experience fear. Psychosis Lana's disoriented state is not an uncommon symptom for chronic users of synthetic cannabis. Her inability to distinguish her location and her screaming indicates she is experiencing a psychotic episode. Welter et al. (2017) found that 71.4% of inpatient psychiatric patients who abused synthetic cannabis were diagnosed with a psychotic disorder. 61.5% of psychiatric patients diagnosed with a psychotic disorder did not use synthetic cannabis. A higher percentage of psychotic disorders is correlated with synthetic cannabis usage, establishing a relationship between synthetic cannabis and psychotic disorders.   Chronic exposure to synthetic cannabis results in psychosis due to the interactions with the Dopamine-1 and Dopamine-2 receptors as they are associated with cognitive dysfunction and psychotic symptoms (Fantegrossi et al., 2018). Synthetic cannabinoids increase the interaction of the 2A dopamine receptor within the prefrontal cortex as this receptor responds to antipsychotic drugs. The 2A receptor regulates impulse control and mood and is located in the central nervous system (Fantegrossi et al., 2018). Psychosis manifests as chronic exposure to synthetic cannabis prevents alterations in the serotonin 2A receptor expression (Fantegrossi et al., 2018). This exposure increases susceptibility for users to experience altered perceptions and hallucinations. The altercations are the underlying cause of psychosis and drug addiction, explaining why Lana experienced psychosis and has an addiction as she has been smoking for eight months. (Fantegrossi et al., 2018). Fantegrossi et al. (2018) reviewed six studies of synthetic cannabinoid users and found a direct correlation to psychosis and psychotic symptoms. Tachycardia “There was a bolt of lightning in the body and my heart started racing like I was having a heart attack.” (Soussan et al., 2014). Smoking synthetic cannabis can induce tachycardia, causing the heart to beat abnormally fast. Users report experiencing heart pains, respiratory difficulties, muscle tension, and general body pain (Soussan et al., 2014). These symptoms can induce feelings of fear and discomfort. When the CB1 receptor is blocked, atheroma formation is directly reduced. Atheroma formation is the build-up of fatty deposits and scar tissue on the heart, restricting circulation and increasing chances of heart-related altercations (Zaleta et al., 2016). Since synthetic cannabinoids are agonists to the CB1 receptor, this increases the possibility of atheroma formation and, therefore, explains Lana's symptoms of chest pains and tachycardia (Zaleta et al., 2016). Case Study Part 4 Quiz: Cardiac Problems and Psychosis Lana is admitted to the hospital. They do a routine check on her, Lana states that she has been smoking spice for the past eight months and had it earlier in the day. A routine drug test is done. What is Lana’s result? 1. Cannabis is detected in Lana's system 2. Cannabis is not detected in Lana's system Answer 1. Incorrect 2. Correct Lana’s drug test does not pick up cannabis in her system (Millis et al., 2018). Synthetic Cannabinoids - Dependence and Withdrawal Long term abuse of synthetic cannabinoids causes a strong dependence, producing withdrawal symptoms that negatively impact quality of life and mental health (Soussan et al., 2014). Case Study Part 5: Withdrawal and Dependence Lana realizes that her addiction is ruining her life. Lana has poor memory and motor skills; she requires help on her daily tasks. She quits with professional help but experiences withdrawal symptoms including headaches, anxiety, stomach aches, sweating, and vomiting (Soussan et al., 2014). This causes Lana to feel sad, due to her loss of control and loss of her normal life, she is in a state of distress as she is unable to soothe her cravings. Long-term chronic use of synthetic cannabinoids causes dependency and withdrawal from not smoking (Soussan et al., 2014). Quitting warrants feeling of restlessness, aggression, agitation, and uncontrollable mood swings and shifts in emotional states (Soussan et al., 2014). Basic human functions including hunger and sleep are disturbed from the withdrawal. Mental health problems and difficulties in daily functioning can manifest as withdrawal causes insomnia and loss of appetite (Soussan et al., 2014). Quitting synthetic cannabis often warrants the desire to consume other drugs to distract themselves from the urge to consume synthetic cannabis, causing individuals to develop a dependency on other substances (Soussan et al., 2014). Lana is dependent on synthetic marijuana and is experiencing withdrawal symptoms characterized by her memory impairments, concentration difficulties, agitation, and feelings of disconnection, causing her to be emotionally numb. She experiences mood swings and uncontrolled agitation (Akram et al., 2019). The study by Akram et al (2019) revealed that individuals who quit synthetic marijuana have suicidal and depressive thoughts. Other symptoms include diarrhoea, insomnia, and sweating (Akram et al., 2019). “The side effect for me was unfortunately and solely a strong addiction. A dependency appeared as soon as I tried to relax or sleep.” (Soussan et al., 2014). “Used it daily and my temper went up and down and I also became sad and depressed for nothing.” (Soussan et al., 2014). Most Common Symptoms of Synthetic Cannabinoids As the chemical formulations of synthetic cannabinoid mixes vary, binding affinity to the CB1 and CB2 receptors vary, producing unpredictable symptoms (Alexandre et al., 2020). Users can experience a combination of the following symptoms depending on their dose and previous usage (Alexandre et al., 2020). COGNITIVE SYMPTOMS PHYSICAL SYMPTOMS PSYCHO-SOCIAL AND BEHAVIOURAL SYMPTOMS Confusion (Synthetic Marijuana Abuse, 2021) Panic attacks (Synthetic Marijuana Abuse, 2021) Extreme anxiety (Synthetic Marijuana Abuse, 2021) Delusion (Synthetic Marijuana Abuse, 2021) Headaches (Wells, 2011) Psychosis. An individual’s genetic predisposition determines the likeliness of experiencing psychosis (Cohen et al., 2020) Hallucinations (Wells, 2011) Reduced or elevated blood pressure (Synthetic Marijuana Abuse, 2021) Extreme depressive episodes (Synthetic Marijuana Abuse, 2021) Paranoia (Wells, 2011) Muscle spasms (Wells, 2011) Sudden and extreme periods of hyperactivity (Synthetic Marijuana Abuse, 2021) Disorientation (Synthetic Marijuana Abuse, 2021) Chest pains, heart palpitations and tachycardia (Wells, 2011) Sudden and extreme periods of lethargy (Synthetic Marijuana Abuse, 2021) Altered perceptions (Synthetic Marijuana Abuse, 2021) Vomiting and diarrhoea (Soussan et al., 2014) Sudden, unprovoked, and severe anger outbursts (Synthetic Marijuana Abuse, 2021) Depersonalization (Synthetic Marijuana Abuse, 2021) Poor coordination (Cohen et al., 2020) Physical aggression (Synthetic Marijuana Abuse, 2021) Racing thoughts (Wells, 2011) Slurred speech (Wells, 2011) Irritability (Wells, 2011) Conclusion Synthetic cannabinoids are a human-made drug that replicates the feeling of natural cannabis (Byard & Payne-James, 2015). Consumption of synthetic cannabinoids results in adverse psychical, behavioral, cognitive, and psychosocial symptoms determined by the binding affinity to the CB1 and CB2 receptors (Samaan et al., 2016). Research literature concludes that intoxication warrants euphoric feelings due to the CB1 receptor. Short-term and long-term memory problems occur, causing individuals to experience confusion due to disruptions in the hippocampus (Cohen et al., 2017). Synthetic cannabis causes users to experience depression and delusions due to decreased serotonin levels (Cohen et al., 2017). Psychosis manifests in chronic synthetic cannabis users due to the interactions with dopamine receptors (Fantegrossi et al., 2018). Users often experience tachycardia to the cannabinoid interaction with the CB1 receptor, promoting atheroma formations (Zaleta et al., 2016). Synthetic cannabis is addictive and withdrawal is characterized by depression, suicidal thoughts, and urges to consume other drugs (Soussan et al., 2014). Synthetic cannabis causes unpredictable emotional, physical, cognitive, and psycho-social symptoms, thus the conclusion is it should be avoided and not consumed (Millis et al., 2018). See Also Adolescent substance use motivation (Book chapter, 2014) Addiction (Book chapter, 2021) Cannabis and anxiety (Book chapter, 2016) Cannabis and emotion (Book chapter, 2013) Cannabis and negative emotions (Book chapter, 2016) Cannabis and positive emotions (Book chapter, 2017) Drug use Vs Drug Addiction (Book chapter, 2018) Effect of cannabis on motivation (Book chapter, 2014) Euphoria as an emotion (Book chapter, 2017) Sensation Seeking (Book chapter, 2011) (Simple Wikipedia) References Akram, H., Mokrysz, C., & Curran, H. V. (2019). What are the psychological effects of using synthetic cannabinoids? A systematic review. Journal of Psychopharmacology, 33(3), 271–283. https://doi.org/10.1177/0269881119826592 Alexandre, J., Carmo, H., Carvalho, F., & Silva, J. P. (2020). Synthetic cannabinoids and their impact on neurodevelopmental processes. Addiction biology, 25(2), e12824. https://doi.org/10.1111/adb.12824 Baddeley, A. (1992). Working memory. Science, 255(5044), 556-559. https://doi.org/10.1126/science.1736359 Byard, R., & Payne-James, J. (2015). Encyclopedia of forensic and legal medicine. Academic Press. https://doi.org/10.1007/s00414-005-0067-5 Cohen, K., Kapitány-Fövény, M., Mama, Y., Arieli, M., Rosca, P., Demetrovics, Z., & Weinstein, A. (2017). The effects of synthetic cannabinoids on executive function. Psychopharmacology, 234(7), 1121-1134. https://doi.org/10.1007/s00213-017-4546-4 Cohen, K., Mama, Y., Rosca, P., Pinhasov, A., & Weinstein, A. (2020). Chronic use of synthetic cannabinoids is associated with impairment in working memory and mental flexibility. Frontiers in psychiatry, 11, 602. https://doi.org/10.3389/fpsyt.2020.00602 Cottencin, O., Rolland, B., & Karila, L. (2014). New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature. Current pharmaceutical design, 20(25), 4106-4111. https://doi.org/10.2174/13816128113199990622 Hoyte, C. O., Jacob, J., Monte, A. A., Al-Jumaan, M., Bronstein, A. C., & Heard, K. J. (2012). A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Annals of emergency medicine, 60(4), 435-438. https://doi.org/10.1016/j.annemergmed.2012.03.007 Mills, B., Dishner, E., & Velasco, C. E. (2018, April). Acute myocardial infarction triggered by use of synthetic cannabis. In Baylor University Medical Center Proceedings (Vol. 31, No. 2, pp. 200-202). Taylor & Francis. https://doi.org/10.1080/08998280.2017.1416243 Soussan, C., & Kjellgren, A. (2014). The Flip Side of “Spice”: The Adverse Effects of Synthetic Cannabinoids as Discussed on a Swedish Internet Forum. Nordic Studies on Alcohol and Drugs, 31(2), 207–220. https://doi.org/10.2478/nsad-2014-0016 Sutcliffe, O. Ralphs, R. (2018). What is Spice and why is the drug so dangerous? https://theconversation.com/what-is-spice-and-why-is-the-drug-so-dangerous-60600 Synthetic Marijuana Abuse & Addiction Effects, Signs & Symptoms. (2021). Mount Regis Center. https://www.mtregis.com/addiction/synthetic-marijuana/effects-signs-symptoms/ Wells DL, Ott CA. The “New” Marijuana. Annals of Pharmacotherapy. 2011;45(3):414-417. https://doi.org/10.1345/aph.1P580 Winstock, A. R., & Barratt, M. J. (2013). Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and alcohol dependence, 131(1-2), 106-111. https://doi.org/10.1016/j.drugalcdep.2012.12.011 Zaleta, S., Kumar, P., & Miller, S. (2016). Chest pain, troponin rise, and ST-elevation in an adolescent boy following the use of the synthetic cannabis product K2. Annals of pediatric cardiology, 9(1), 79. https://doi.org/10.4103/0974-2069.171400 External links Addiction (Reach Out) HHC, Spice and Cannabis Synthetics. This Is What You Need To Know: (CBD Testers) Spice Addiction & Rehab (MentalHealth.net) Spice rehab treatment: What to expect? (Addiction Blog) Synthetic Cannabis (Alcohol and Drug Foundation) Synthetic cannabinoids (Wikipedia) The 6 Types of Basic Emotions and Their Effect on Human Behavior (Very Well Mind) What is Spice and Why is the Drug so Dangerous? (The Conversation)